[go: up one dir, main page]

Pucci et al., 2013 - Google Patents

Improving the bioactivity of Zn (II)-curcumin based complexes

Pucci et al., 2013

View PDF
Document ID
14390508169318476947
Author
Pucci D
Crispini A
Mendiguchía B
Pirillo S
Ghedini M
Morelli S
De Bartolo L
Publication year
Publication venue
Dalton Transactions

External Links

Snippet

New Zn (II)-curcumin based heteroleptic complexes (1–5) have been synthesized and fully characterized, with the aim to improve the bioactivity of the precursor derivative [(bpy-9) Zn (curc) Cl](A), a potentially intercalating antitumor agent recently reported. Some structural …
Continue reading at www.researchgate.net (PDF) (other versions)

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P-C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System compounds of the platinum group
    • C07F15/0073Rhodium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic System
    • C07F5/02Boron compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F17/00Metallocenes
    • C07F17/02Metallocenes of metals of Groups 8, 9 or 10 of the Periodic System
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom

Similar Documents

Publication Publication Date Title
Pucci et al. Improving the bioactivity of Zn (II)-curcumin based complexes
Subarkhan et al. Synthesis and molecular structure of arene ruthenium (II) benzhydrazone complexes: impact of substitution at the chelating ligand and arene moiety on antiproliferative activity
Colina-Vegas et al. Half sandwich Ru (II)-acylthiourea complexes: DNA/HSA-binding, anti-migration and cell death in a human breast tumor cell line
Subarkhan et al. Ruthenium (II) arene complexes containing benzhydrazone ligands: synthesis, structure and antiproliferative activity
Arcau et al. Luminescent alkynyl-gold (I) coumarin derivatives and their biological activity
Čanović et al. Impact of aromaticity on anticancer activity of polypyridyl ruthenium (II) complexes: synthesis, structure, DNA/protein binding, lipophilicity and anticancer activity
Pierroz et al. Molecular and cellular characterization of the biological effects of ruthenium (II) complexes incorporating 2-pyridyl-2-pyrimidine-4-carboxylic acid
Chen et al. Lysosome-targeted iridium (III) compounds with pyridine-triphenylamine Schiff base ligands: syntheses, antitumor applications and mechanisms
Lo et al. Iridium (III) complexes as therapeutic and bioimaging reagents for cellular applications
Gimeno et al. Conjugates of ferrocene with biological compounds. Coordination to gold complexes and antitumoral properties
Yu et al. Supramolecular enhancement of aggregation-induced emission and its application in cancer cell imaging
Cafeo et al. Drug delivery with a calixpyrrole–trans-Pt (II) complex
Galassi et al. Synthesis and characterization of azolate gold (I) phosphane complexes as thioredoxin reductase inhibiting antitumor agents
Mendiguchia et al. Zn (II) and Cu (II) complexes containing bioactive O, O-chelated ligands: homoleptic and heteroleptic metal-based biomolecules
Gavara et al. Study of the effect of the chromophore and nuclearity on the aggregation and potential biological activity of gold (I) alkynyl complexes
Joksović et al. Synthesis, characterization and antitumor activity of novel N-substituted α-amino acids containing ferrocenyl pyrazole-moiety
Yilmaz et al. Synthesis, structures and biomolecular interactions of new silver (I) 5, 5-diethylbarbiturate complexes of monophosphines targeting Gram-positive bacteria and breast cancer cells
Czerwińska et al. Cytotoxic gold (III) complexes incorporating a 2, 2′: 6′, 2′′-terpyridine ligand framework–the impact of the substituent in the 4′-position of a terpy ring
Sarkar et al. Remarkable visible light-triggered cytotoxicity of mitochondria targeting mixed-ligand cobalt (III) complexes of curcumin and phenanthroline bases binding to human serum albumin
Gupta et al. Anticancer activity of large metalla-assemblies built from half-sandwich complexes
Zahirović et al. Type of complex–BSA binding forces affected by different coordination modes of alliin in novel water-soluble ruthenium complexes
Kozieł et al. Anticancer potency of novel organometallic Ir (III) complexes with phosphine derivatives of fluoroquinolones encapsulated in polymeric micelles
Mondal et al. Hypoxia efficient and glutathione-resistant cytoselective ruthenium (II)-p-cymene-arylimidazophenanthroline complexes: biomolecular interaction and live cell imaging
Icsel et al. Structures and anticancer activity of chlorido platinum (II) saccharinate complexes with mono-and dialkylphenylphosphines
Subran et al. Amberlite IR-120 (H)-mediated “on water” synthesis of novel anticancer ruthenium (II)–p-cymene 2-pyridinylbenzothiazole (BTZ), 2-pyridinylbenzoxazole (BOZ) & 2-pyridinylbenzimidazole (BIZ) scaffolds